Global AI in Drug Discovery Market Size, Competitive Analysis, Share, Forecast- 2019-2025


Posted August 28, 2020 by preetipandey

The global AI in drug discovery market is estimated to grow significantly, at a CAGR of 51.3%, during the forecast period.

 
The global AI in drug discovery market is estimated to grow significantly, at a CAGR of 51.3%, during the forecast period. AI has the potential to enhance the drug discovery process, diminish failure rates during clinical trials, reduce R&D expenses, and ultimately produce a superior medicine for the healthcare sector. There are several drug discovery and pharma companies have started working in conjunction with software companies for implementing the most advanced technologies that require costly and extensive drug discovery process. AI-driven computer programs can accurately and promptly analyze structures of a range of drug molecules and predict adverse effects, potency, and pharmacological activities of the drug. This possibility has the potential to develop a rapid and inexpensive route of drug discovery.

Get Free Sample Copy @https://www.omrglobal.com/request-sample/ai-in-drug-discovery-market

AI stands out to be one of the biggest technological breakthroughs in the healthcare sector; however, there are lots of security concerns associated with this technology, which hampers the growth of the market at the global level. In addition, the lack of relevant data input to AI-assisted healthcare devices may result in hampering the market growth during the forecast period. Despite these restraining factors, with the increasing prevalence of diseases, the need for the advanced drug is rising. Every pharma company strives to develop a new innovative drug. In order to achieve this goal, companies spend heavily on R&D department. These investments are expected to offer growth opportunities to the AI in drug discovery market during the forecast period.

Browse for Full Report [email protected] https://www.omrglobal.com/industry-reports/ai-in-drug-discovery-market

Market Segmentation

Global AI in Drug Discovery Market by Application
Oncology
CVD
Neurodegenerative Diseases
Others (Metabolic Diseases)
Global AI in Drug Discovery Market by End-User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic Organizations
Regional Analysis

North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles

AiCure, LLC
Atomwise, Inc.
BenevolentAI
Biovista
Deep Genomics
Desktop Genetics Ltd.
Exscientia Ltd.
Google LLC
IBM Corp.
IKTOS
Insilico Medicine, Inc.
Intel Corp.
Microsoft Corp.
NuMedii Inc.
Numerate, Inc.
Owkin Inc.
Recursion Pharmaceuticals Inc.
TwoXAR, Inc.
XtalPi Inc.
For More Customized Data, Request for Report Customization @https://www.omrglobal.com/report-customization/ai-in-drug-discovery-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari

Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By preeti
Country India
Categories Business
Tags Global AI in Drug Discovery Market
Last Updated August 28, 2020